Chronic low-grade inflammation represents one of the most common physiological burdens in modern environments. Persistent inflammatory signaling, mucosal imbalance, and slow tissue regeneration can progressively affect structural integrity across multiple systems.

ABIMPROSYC REGENERA has been formulated to provide structured inflammatory support from a biofunctional perspective—without immunosuppressive mechanisms and without therapeutic positioning.

Its architecture is designed for progressive structural restoration while maintaining immune equilibrium.

Compatible Physiological Profiles

ABIMPROSYC REGENERA is oriented toward individuals who experience:

Ongoing exposure to low-grade inflammatory processes

Stabilized autoimmune backgrounds requiring structural support

Slow tissue repair dynamics

Imbalance in the mucosal–immune axis

Digestive vulnerability

Joint structural stress

Epithelial integrity challenges

The model does not aim to treat inflammatory disease.
It supports structural resilience within inflammatory-prone environments.

Biostructural Axes of REGENERA

The formulation integrates coordinated functional families organized around key inflammatory and structural pathways.

Modulation of Proinflammatory Signaling

Includes compounds compatible with the regulation of chronic proinflammatory pathways such as:

NF-κB

COX-2

NLRP3 inflammasome activity

The objective is pathway compatibility and structural balance, not pharmacological inhibition.

Support for Endogenous Antioxidant Systems

Oxidative stress often accompanies chronic inflammatory load. REGENERA integrates redox-aligned compounds that support endogenous antioxidant systems, including:

Glutathione (GSH) dynamics

Catalase activity

Superoxide dismutase (SOD) function

This axis contributes to maintaining intracellular oxidative equilibrium during periods of structural demand.

Intestinal Symbiotic Synchronization

The mucosal-immune interface plays a central role in inflammatory balance.

REGENERA incorporates encapsulated symbiotic strains, protected within a dry vegetable capsule independent of the liquid phase. This architecture supports intestinal ecosystem coherence without compromising strain viability.

Integration of Structural Peptides and Mineral Cofactors

Structural repair requires biochemical substrates. The formulation includes:

Collagen peptides

Zinc

Magnesium

These components contribute to connective tissue integrity, epithelial barrier support, and enzymatic cofactor availability within structural recovery processes.

Progressive Structural Restoration Without Immunosuppression

ABIMPROSYC REGENERA is positioned within advanced nutritional immunoceuticals, emphasizing:

Structural compatibility

Redox stabilization

Mucosal synchronization

Connective tissue reinforcement

It does not induce immunosuppression.
It does not operate through pharmacological anti-inflammatory mechanisms.

Instead, it supports endogenous regulatory systems through coordinated biofunctional architecture.

A Precision Approach to Inflammatory Balance

In modern health contexts, chronic low-grade inflammation often persists beneath the surface of overt pathology. Addressing this landscape requires structural coherence—not isolated anti-inflammatory compounds.

ABIMPROSYC REGENERA reflects a Fourth Generation nutraceutical framework:

Multiphasic.
Chronoadaptive.
Symbiotically integrated.
Structurally aligned.

Designed for individuals seeking progressive restoration and resilience within inflammatory-prone physiological scenarios—while maintaining regulatory integrity and non-therapeutic positioning.

nutraceuticos #salud #bienestar #mexico #latinoamerica